Non-invasive imaging of tumor pd-l1 expression using radiolabeled anti-pd-l1 antibodies

The present invention relates to a method for identifying patients suffering
from or suspected to suffer from a cancer involving a solid tumor

Keywords: PD-L1, imaging, radiolabel
Patent Application number: European Procedure (Patents) (EPA) - 07 Avr. 2015 - 15305510.8

Reference:

BIO15048-T1

Business Developper
contact
Inserm Transfert
Business Developer
Patent filling date: 07-04-2015
Rare disease: No
Second indication: No

You might also be interested in